RE-PRESENT collaborates with the Contigo Foundation

14 Oct,2026 | Sin categorizar

Why the Contigo Foundation?

BECAUSE 1 IN 8 WOMEN WILL DEVELOP BREAST CANCER IN THEIR LIFETIME

The Contigo Foundation works tirelessly every day to find increasingly better treatments that will allow us to finally say to cancer: ENOUGH!

 

BECAUSE AROUND 34,750 NEW CASES OF BREAST CANCER ARE DIAGNOSED EACH YEAR IN SPAIN AND MORE THAN 2,300,000 WORLDWIDE

The Contigo Foundation is committed to better diagnosis and treatment, and to this end it has a multidisciplinary scientific committee with 20 years of experience in the specialty and recognized international prestige.

 

BECAUSE TODAY 6,572 WOMEN DIE FROM BREAST CANCER IN SPAIN EACH YEAR

Reducing mortality from cancer in women requires investing in research that transforms science and allows progress in the fight against all types of cancer in women.

 

FOR ALL THESE REASONS

In 2021, Dr. Javier Cortés decided to create the Contigo Foundation, with the aim of promoting research exclusively on Women’s Cancer.

Why Fundación Contigo?

SCIENTIFIC EXCELLENCE

DR. JAVIER CORTÉS CASTÁN

President of the Contigo Foundation against Women’s Cancer.

GIANTS OF CANCER CARE 2026

GIANTS OF CANCER CARE 2026

The only Spanish oncologist awarded in this edition.

#1 IN HER2 POSITIVE BREAST CANCER

#1 IN HER2 POSITIVE BREAST CANCER

Ranking Internacional Expertscape.

DIRECTOR OF THE INTERNATIONAL BREAST CANCER CENTER (IBCC)

DIRECTOR OF THE INTERNATIONAL BREAST CANCER CENTER (IBCC)

Specialized centers in Madrid and Barcelona.

FOUNDER OF MEDICA SCIENTIA INNOVATION RESEARCH (MEDSIR)

FOUNDER OF MEDICA SCIENTIA INNOVATION RESEARCH (MEDSIR)

International group dedicated to the design and development of clinical trials in oncology.

EXPERIENCE AND RECOGNITION

EXPERIENCE AND RECOGNITION

More than 550 international publications and more than 800 lectures at different world congresses.

GLOBAL IMPACT

GLOBAL IMPACT

He has directly contributed to the approval of 12 new treatments for metastatic breast cancer, including TRASTUZUMAB, considered one of the most important advances in recent years in the treatment of Her2 positive breast cancer.

DR. JAVIER CORTÉS CASTÁN

Scientific knowledge is our starting point, the impact on patients is our goal.

Mission of the Contigo Foundation

COMMITMENT TO RESEARCH

The Contigo Foundation is dedicated to funding women’s cancer research projects, promoting scientific progress and improving the lives of patients.

 

REAL IMPACT

The research projects supported by the foundation have the potential to transform the diagnosis, treatment, and prevention of women’s cancer.

 

“”RESEARCH HEALS”

Mission of the Contigo Foundation

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Fundación contigo contra el cáncer de mama
BodaMás El Corte Inglés: Proveedor Regsitrado
Financiado por la Unión Europea, NextGeneretionEu, Gobierno de España, Ministerio de Industria, Comercio y Turismo, Plan de Recuperación, Transformación y Resilencia